Expression of Molecular Markers of Angiogenesis, Lymphangiogenesis, and Proliferation Depending on the Stage of Skin Melanoma


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The expression of molecular markers characterizing activity of the tumor process and metastases (proliferation marker Ki-67, angiogenesis marker CD34, and lymphangiogenesis markers podoplanin and LYVE-1) was assessed by immunohictochemical method in the primary tumor specimens collected during surgery for cutaneous melanoma (40 patients). Proliferative activity of the tumor tissue and volume density of peritumoral blood and lymph vessels increased with increasing tumor malignancy, which could indicate the risk of metastases.

About the authors

N. P. Bgatova

Institute of Clinical and Experimental Lymphology

Author for correspondence.
Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

A. I. Lomakin

Novosibirsk Regional Clinical Oncological Center

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

S. A. Fursov

Novosibirsk Regional Clinical Oncological Center

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

I. V. Kachesov

Novosibirsk Regional Clinical Oncological Center

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

S. A. Chepko

Novosibirsk Regional Clinical Oncological Center

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

N. B. Isakova

Novosibirsk Regional Clinical Oncological Center

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

Yu. I. Borodin

Institute of Clinical and Experimental Lymphology

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

V. E. Voytsitsky

Novosibirsk Regional Clinical Oncological Center

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk

V. I. Konenkov

Institute of Clinical and Experimental Lymphology

Email: n_bgatova@ngs.ru
Russian Federation, Novosibirsk


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies